| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |